Asensus Surgical (GB:0LG9)

Asensus Surgical (0LG9) Stock Price & Analysis


0LG9 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$16.38 - $16.38
Previous Close$16.38
Average Volume (3M)N/A
Market Cap
Enterprise Value$81.52M
Total Cash (Recent Filing)$70.52M
Total Debt (Recent Filing)$5.54M
Price to Earnings (P/E)-51.3
May 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding239,279,746
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)1.59
Price to Sales (P/S)77.70
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.50
Enterprise Value/Gross Profit-21.54
Enterprise Value/Ebitda-1.28
Price Target Upside-87.79% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1




What was Asensus Surgical’s price range in the past 12 months?
Asensus Surgical lowest stock price was $16.38 and its highest was $16.38 in the past 12 months.
    What is Asensus Surgical’s market cap?
    Currently, no data Available
    When is Asensus Surgical’s upcoming earnings report date?
    Asensus Surgical’s upcoming earnings report date is May 09, 2023 which is in 42 days.
      How were Asensus Surgical’s earnings last quarter?
      Asensus Surgical released its earnings results on Mar 02, 2023. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.075 by $0.005.
        Is Asensus Surgical overvalued?
        According to Wall Street analysts Asensus Surgical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Asensus Surgical pay dividends?
          Asensus Surgical does not currently pay dividends.
          What is Asensus Surgical’s EPS estimate?
          Asensus Surgical’s EPS estimate is -$0.08.
            How many shares outstanding does Asensus Surgical have?
            Asensus Surgical has 239,279,740 shares outstanding.
              What happened to Asensus Surgical’s price movement after its last earnings report?
              Asensus Surgical reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.075. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Asensus Surgical?
                Currently, no hedge funds are holding shares in GB:0LG9


                Asensus Surgical Stock Smart Score

                The Asensus Surgical Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Asensus Surgical

                TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Sensus Healthcare
                Asensus Surgical

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis